Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 1
2005 4
2006 4
2007 3
2008 3
2009 4
2010 4
2011 6
2012 2
2013 9
2014 3
2015 2
2016 4
2017 5
2018 6
2019 2
2020 3
2021 6
2022 6
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Reply.
Pertl L, Haas A, Hausberger S, Pichler T, Rabensteiner D, Seidel G, Malle EM, Weger M. Pertl L, et al. Among authors: weger m. Retina. 2018 Jun;38(6):e45. doi: 10.1097/IAE.0000000000002167. Retina. 2018. PMID: 29664822 No abstract available.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Long-term life history predicts current gut microbiome in a population-based cohort study.
Si J, Vázquez-Castellanos JF, Gregory AC, Decommer L, Rymenans L, Proost S, Centelles Lodeiro J, Weger M, Notdurfter M, Leitner C, Santer P, Rungger G, Willeit J, Willeit P, Pechlaner R, Grabherr F, Kiechl S, Tilg H, Raes J. Si J, et al. Among authors: weger m. Nat Aging. 2022 Oct;2(10):885-895. doi: 10.1038/s43587-022-00286-w. Epub 2022 Oct 14. Nat Aging. 2022. PMID: 37118287 Free PMC article.
Heme oxygenase-1 gene rs2071746 polymorphism in retinal vein occlusion.
Posch-Pertl L, List W, Michelitsch M, Pinter-Hausberger S, Berisha B, Posch F, Kloeckl L, Renner W, Weger M. Posch-Pertl L, et al. Among authors: weger m. Ophthalmic Genet. 2022 Oct;43(5):627-632. doi: 10.1080/13816810.2022.2092754. Epub 2022 Jun 27. Ophthalmic Genet. 2022. PMID: 35762119
ENDOTHELIN-1 AS A RISK FACTOR IN RETINAL VEIN OCCLUSION.
List W, Weger M, Pinter-Hausberger S, Posch F, Rabensteiner J, Pailer S, Wedrich A, Posch-Pertl L. List W, et al. Among authors: weger m. Retina. 2022 Apr 1;42(4):738-743. doi: 10.1097/IAE.0000000000003374. Retina. 2022. PMID: 34861658
Inhibition of profibrotic microRNA-21 affects platelets and their releasate.
Barwari T, Eminaga S, Mayr U, Lu R, Armstrong PC, Chan MV, Sahraei M, Fernández-Fuertes M, Moreau T, Barallobre-Barreiro J, Lynch M, Yin X, Schulte C, Baig F, Pechlaner R, Langley SR, Zampetaki A, Santer P, Weger M, Plasenzotti R, Schosserer M, Grillari J, Kiechl S, Willeit J, Shah AM, Ghevaert C, Warner TD, Fernández-Hernando C, Suárez Y, Mayr M. Barwari T, et al. Among authors: weger m. JCI Insight. 2018 Nov 2;3(21):e123335. doi: 10.1172/jci.insight.123335. JCI Insight. 2018. PMID: 30385722 Free PMC article.
High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration.
Pertl L, Kern S, Weger M, Hausberger S, Trieb M, Gasser-Steiner V, Haas A, Scharnagl H, Heinemann A, Marsche G. Pertl L, et al. Among authors: weger m. PLoS One. 2016 May 12;11(5):e0154397. doi: 10.1371/journal.pone.0154397. eCollection 2016. PLoS One. 2016. PMID: 27171197 Free PMC article.
82 results